Astria Therapeutics, Inc. Common Stock logo

ATXS Q3 2025 Earnings Results — Astria Therapeutics, Inc. Common Stock

XNAS · Healthcare · Biotechnology

Updated

Price $12.53
Market Cap $706.9M
P/E —
52W Range $7.19 – $13.29

When is ATXS's next earnings date?

Astria Therapeutics, Inc. Common Stock (ATXS) has not announced its next earnings date yet. Its most recent earnings report was on Wednesday, November 12, 2025.

How did ATXS do in its last earnings report?

In its most recent report on Nov 12, 2025 (Q3 2025), Astria Therapeutics, Inc. Common Stock posted EPS of -$0.55 versus the -$0.42 estimate, a miss of 30.9%. Revenue was $706,000 against a $12.8M estimate. The stock's 1-day post-earnings move was +0.3%.

How much does ATXS stock move after earnings?

ATXS beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.4% (up or down) in the day after earnings.

About Astria Therapeutics, Inc. Common Stock

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2025-11-12Q3 2025-0.42-0.55-30.95%$706,000❌ Miss+0.32%-0.16%+3.20%
2025-08-12Q2 2025-0.59-0.57+3.39%$0✅ Beat+3.31%-5.26%+17.89%
2025-03-11Q4 2024-0.45-0.44+2.22%$0✅ Beat+11.17%+11.34%-35.57%
2024-11-13Q3 2024-0.41-0.42-2.44%$0❌ Miss-4.90%-9.71%-10.27%
2024-08-12Q2 2024-0.38-0.43-13.16%$0❌ Miss+7.48%+19.67%+8.91%
2024-03-04Q4 2023-0.78-0.86-10.26%$0❌ Miss-2.88%+1.89%-15.15%
2023-11-13Q3 2023-0.49-0.63-28.57%$0❌ Miss-2.39%-3.91%+16.09%
2023-08-07Q2 2023-0.49-0.45+8.16%$0✅ Beat+2.47%+2.72%+10.26%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .